EY: Shifting into high gear: Mitigating risks and demonstrating returns

Forensic data analytics (FDA) has evolved considerably over the past two years. In our 2014 survey, we found that, although companies were deploying some forms of FDA, many were missing opportunities to leverage emerging advanced tools that would enable them to greatly strengthen and improve their risk management and investigative response programs.